PYK2 role in tumourigenesis and in breast cancer invasion is well known [24, 34], and thus, we selected this molecule for further studies to determine its role in HER2+/ER−/PR- breast cancer and in response to metformin treatment. This evidence concerns the gene ESR1 and breast carcinoma.